Inovio Pharmaceuticals Reports Positive Data

Inovio Pharmaceuticals Reports Positive Data

Inovio Pharmaceuticals shares were up nearly 3% in pre-market trading after it said its Zika vaccine protected against Zika virus-induced damage to testes and sperm. The company said the vaccine also prevented persistence of the virus in the reproductive tract of all vaccinated male mice challenged with a high dose of the Zika virus. Inovio is developing the vaccine, GLS-5700, with GeneOne Life Science, Inc., and academic collaborators from the […]

Read More ˃